ADAM J BARD

Allopathic & Osteopathic Physicians|Internal Medicine FAIRFIELD, CT NPI 1477531218

General Payments — all program years on this page

$2,027.21

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 119
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $465.57 across 18 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $465.5718

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $248.9515
2019 $119.047
2020 $487.2428
2021 $138.5413
2022 $280.8216
2023 $287.0522
2024 $465.5718

Records — PY2024 (18)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1097092209 Novo Nordisk Inc $18.84 11/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097286379 Novo Nordisk Inc $23.67 08/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103278869 ABBVIE INC. $15.83 03/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104263701 AstraZeneca Pharmaceuticals LP $13.80 11/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104514880 AstraZeneca Pharmaceuticals LP $19.33 03/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105344956 AstraZeneca Pharmaceuticals LP $21.08 07/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105717858 AstraZeneca Pharmaceuticals LP $128.33 01/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117197693 Amgen Inc. $13.24 01/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117197695 Amgen Inc. $18.51 06/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117197697 Amgen Inc. $19.52 09/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117197699 Amgen Inc. $20.30 11/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1130881048 PFIZER INC. $21.20 10/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131430393 PFIZER INC. $17.84 12/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131655684 PFIZER INC. $18.78 07/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131677509 PFIZER INC. $18.52 06/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133896111 Vanda Pharmaceuticals Inc. $16.74 10/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133896113 Vanda Pharmaceuticals Inc. $33.28 12/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153488495 Salix Pharmaceuticals, a division of Bausch Health US, LLC $26.76 09/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.